A phase I clinical study of autologous dendritic cell therapy in patients with relapsed or refractory multiple myeloma

Cellular immunotherapy is emerging as a potential immunotherapeutic modality in multiple myeloma (MM). We have developed potent immunotherapeutic agent (VAX-DC/MM) generated by dendritic cells (DCs) loaded with autologous myeloma cells irradiated with ultraviolet B. In this study, we evaluated the s...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncotarget
Asıl Yazarlar: Jung, Sung-Hoon, Lee, Hyun-Ju, Lee, Youn-Kyung, Yang, Deok-Hwan, Kim, Hyeoung-Joon, Rhee, Joon Haeng, Emmrich, Frank, Lee, Je-Jung
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Impact Journals LLC 2017
Konular:
Clinical Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5522196/
https://ncbi.nlm.nih.gov/pubmed/28088784
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14582
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller